Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

YELLOW FEVER VACCINE

Awarded
SPE2DP27F0223Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency awarded contract SPE2DP27F0223 to DMS Pharmaceutical Group Inc for the procurement of Yellow Fever Vaccine. This delivery order was issued under the base administrative contract SPE2DX25D9900, which was established by the DLA Troop Support Medical Supply Chain. The award is designated for the supply of Yellow Fever Vaccine, identified by NSN 6505011715260 and part number NDC49281-0915-01. The order specifies a delivery date of November 3, 2026, with the destination set for Fort Carson, Colorado. While the award notice lists a total contract price of 3,777.24 dollars, the associated delivery order documentation indicates a quantity of 267 units at a unit price of 629.54 dollars, totaling 14,701 dollars. This procurement is part of a broader federal effort managed by the Department of Defense to maintain medical supply chain readiness.

General Info

DLA awarded DMS Pharmaceutical Group 14,701 dollars for Yellow Fever Vaccines by 2026.

Contract Value

$3,777.24

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

2

Contract SPE2DX-25-D-9900

PDF, High priority: read this firstaward
High

Task Order SPEZD-27-F-0223 (Yellow Fever Vaccine)

PDF, High priority: read this firsttask-order-award
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP27F0223 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $3,777.24 Award Date: 10-19-2026 Delivery order under: SPE2DX25D9900 Line items: - YELLOW FEVER VACCINE (NSN/Part 6505011715260, PR 7018795523)

Similar Contracts

Same NAICS industry code

NAICS: 325414
DIBBS
JAPANESE ENCEPHALIT
Solicitation # SPE2DP-26-R-0001
Solicitation SPE2DP-26-R-0001 is a sole source request from the Department of Defense Medical Supply Chain Pharmacy FSA for the procurement of Japanese Encephalitis Virus (JEV) Vaccine, purified and inactivated, in single-dose prefilled syringes. The resulting contract will be a firm-fixed price, indefinite delivery, indefinite quantity (IDIQ) agreement with an eighteen-month base term. The government has established a minimum quantity of 277,760 units and a maximum quantity of 394,240 units, with the guaranteed minimum dollar value obligated at the time of award. Deliveries are required FOB Destination to DLA Distribution Susquehanna within 120 days after the date of order. To be eligible, offerors must provide proof of FDA approval to manufacture or sell the vaccine or a manufacturer's letter of commitment ensuring supply availability and fixed pricing for the contract duration. The product must adhere to MPID Number 5 and Medical Marking Standard No. 1D, specifically requiring cold chain storage between 2-8 degrees Celsius and serialization in accordance with the Drug Supply Chain Security Act. Proposals must be submitted electronically via the DLA Internet Bid Board System (DIBBS) by November 6, 2026, and must include unit pricing, as failure to provide this may lead to proposal rejection. Award will be based on the most advantageous offer considering price, FDA approval, and agreement to all solicitation terms.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

19 days ago

DEADLINE

in 12 days
View Details
NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

24 days ago

DEADLINE

in 17 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS